Grand Pharmaceutical Group Limited (HKG:0512)
6.86
-0.01 (-0.15%)
Apr 10, 2026, 4:09 PM HKT
HKG:0512 Market Cap
HKG:0512 has a market cap or net worth of 24.02 billion as of April 10, 2026. Its market cap has increased by 12.27% in one year.
Market Cap
24.02B
Enterprise Value
26.01B
Revenue
12.28B
Ranking
n/a
PE Ratio
19.36
Stock Price
6.86
Market Cap Chart
Since February 28, 1996, HKG:0512's market cap has increased from 1.42B to 24.02B, an increase of 1,587.00%. That is a compound annual growth rate of 9.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 24.02B | -12.61% |
| Dec 31, 2025 | 27.49B | 63.54% |
| Dec 31, 2024 | 16.81B | 16.78% |
| Dec 29, 2023 | 14.39B | -11.29% |
| Dec 30, 2022 | 16.22B | -29.24% |
| Dec 31, 2021 | 22.93B | -6.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 38.83B |
| China Medical System Holdings | 35.53B |
| Simcere Pharmaceutical Group | 35.46B |
| Sunshine Lake Pharma | 25.07B |
| The United Laboratories International Holdings | 20.64B |
| Xuanzhu Biopharmaceutical | 16.11B |
| Consun Pharmaceutical Group | 14.36B |
| CanSino Biologics | 13.47B |